Previous Article | Next Article ![]()
Applied and Environmental Microbiology, March 1999, p. 1036-1044, Vol. 65, No. 3
Pharmaceutical Technology Laboratories,
Received 11 May 1998/Accepted 14 December 1998
Penicillium decumbens is able to epoxidize
cis-propenylphosphonic acid (cPA) to produce the antibiotic
fosfomycin [FOM; also referred to as phosphonomycin and
(
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A Phosphonate-Induced Gene Which Promotes
Penicillium-Mediated Bioconversion of
cis-Propenylphosphonic Acid to Fosfomycin
)-cis-1,2-epoxypropylphosphonic acid], a bioconversion
of considerable commercial significance. We sought to improve the
efficiency of the process by overexpression of the genes involved. A
conventional approach of isolating the presumed epoxidase and its
corresponding gene was not possible since cPA epoxidation could not be
achieved with protein extracts. As an alternative approach, proteins
induced by cPA were detected by two-dimensional gel electrophoresis.
The observation that a 31-kDa protein (EpoA) was both cPA induced and
overaccumulated in a strain which more efficiently converted cPA
suggested that it might take part in the bioconversion. EpoA was
purified, its amino acid sequence was partially determined, and the
corresponding gene was isolated from cosmid and cDNA libraries with
oligonucleotide probes. The DNA sequence for this gene
(epoA) contained two introns and an open reading frame
encoding a peptide of 277 amino acids having some similarity to
oxygenases. When the gene was subcloned into P. decumbens,
a fourfold increase in epoxidation activity was achieved.
epoA-disruption mutants which were obtained by homologous recombination could not convert cPA to FOM. To investigate the regulation of the epoA promoter, the bialaphos resistance
gene (bar, encoding phosphinothricin acetyltransferase) was
used to replace the epoA-coding region. In P. decumbens, expression of the bar reporter gene was
induced by cPA, FOM, and phosphorous acid but not by phosphoric acid.
*
Corresponding author. Mailing address: Pharmaceutical
Technology Laboratories, Meiji Seika Kaisha, Ltd., 788 Kayama,
Odawara-shi 250, Japan. Phone: (0465) 37 5106. Fax: (0465) 36 2888. E-mail: takeshi_murakami{at}meiji.co.jp.
Applied and Environmental Microbiology, March 1999, p. 1036-1044, Vol. 65, No. 3
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»